FMP
Nevro Corp.
NVRO
NYSE
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.
3.81 USD
0.09 (2.36%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Mr. Kevin R. Thornal
sector
Healthcare
industry
Medical - Devices
website
https://www.nevro.comexchange
NYSE
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.
CIK
0001444380
ISIN
US64157F1030
CUSIP
64157F103
Address
1800 Bridge Parkway
Phone
650 251 0005
Country
US
Employee
1,215
IPO Date
Nov 6, 2014
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
NVRO Financial Summary
CIK
0001444380
Exchange
NYSE
Industry
Medical - Devices
Sector
Healthcare
CUSIP
64157F103
ISIN
US64157F1030
Country
US
Price
3.81
Beta
0.93
Volume Avg.
501.24k
Market Cap
142.77M
Shares
-
52-Week
3.52-21.66
DCF
-18.95
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-2.04
P/B
-
Website
https://www.nevro.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest NVRO News
It looks like there's no news available.
